COVID-19 therapeutics: Current status, access & research needs
In this webinar experts and members of the Therapeutics Working Group discussed the current status of COVID-19 therapeutics, availability of these expensive medicines in low-resource settings, and research needs to advise and guide health policies.
Effective, equitable, and efficient sharing of individual level data: Recommendations, solutions, and ways forward
In this webinar experts and members of the Data Sharing Working Group shared initiatives to promote effective, equitable, and efficient data sharing for COVID-19 clinical research.
Meet Dr Sauman Singh – Coalition representative to the ACT-Accelerator Therapeutics Partnership
Following the coalition’s efforts to increase the representation of researchers from low- and middle-income countries in the ACT-Accelerator Therapeutics Partnership, four coalition members have joined its workstreams. Meet Dr Sauman Singh, from DNDi and IDDO, India, who joined workstream 2.
COVID-19 therapeutics in resource-constrained settings: Where are we and what do we need?
Where are we today with new and emerging therapeutics that would be both effective and affordable in preventing the progression of mild or moderate COVID-19 and thereby prevent hospitalization? A couple of promising treatments have emerged recently, with early efforts underway to make these drugs more available than COVID-19 vaccines have been. What are the current research priorities, and do current efforts meet the needs? These were the key questions addressed in a recent webinar hosted by the COVID-19 Clinical Research Coalition.
Meet Dr Nada Melhem – Coalition representative to the ACT-Accelerator Therapeutics Partnership
Following the coalition’s efforts to increase the representation of researchers from low- and middle-income countries in the ACT-Accelerator Therapeutics Partnership, four coalition members have joined its workstreams. Meet Dr Nada Melhem, from the American University of Beirut in Lebanon, who joined workstream 1 which focuses on rapid evidence assessment of therapeutic candidates.
Building community trust for COVID-19 vaccine confidence and deployment
This third webinar in a series on vaccines by the coalition’s Social Science Working Group brought together experts to discuss issues related to research on vaccines and deployment during COVID-19 pandemic and past epidemics and share lessons learned for building trust to improve COVID-19 vaccination uptake.
Setting up biorepositiories and increasing sequencing capacity to respond to SARS-CoV-2 in LMICs
The Virology, Immunology and Diagnostics Working Group organized a webinar to discuss the role of biorepositories and efforts underway to increase COVID-19 sample preservation and storage, as well as the sequencing capacity in LMICs and strategies for increasing it.